Berberine pharmaceutical wastewater treatment system
By setting up a reactor, a dehydration device, an adsorption resin column and a biochemical treatment device in the berberine pharmaceutical wastewater treatment system, and utilizing alkaline substances to react to generate precipitates and adsorb berberine, the problem of berberine pharmaceutical wastewater treatment was solved, and effective water purification and resource recovery were achieved.
Patent Information
- Application Number
- CN202422605943.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-28
- Publication Date
- 2025-10-14
- Estimated Expiration
- 2034-10-28
AI Technical Summary
Berberine pharmaceutical wastewater contains a high concentration of berberine, which has a strong antibacterial effect and microbial toxicity, making aerobic and anaerobic treatment difficult, and has poor biodegradability, making it difficult to effectively treat with conventional biochemical treatment.
The method uses a reactor, a first dehydration device, a macroporous adsorption resin column, a resin filter and a biochemical treatment device which are connected in sequence. Alkaline substances react with copper ions in wastewater to generate copper hydroxide, which further generates basic copper chloride precipitate. The resin filter is used to adsorb berberine. The ion exchange resin column and the resin desorption column are combined to recover the berberine and purify the water quality.
It effectively removes copper ions, chloride ions and berberine in wastewater, improves water quality, enhances the biodegradability of wastewater, and achieves effective wastewater treatment.
Smart Images

Figure CN223433343U_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of water treatment technology, and in particular to a berberine pharmaceutical wastewater treatment system. Background Art
[0002] Berberine, also known as berberine hydrochloride, is a yellow or white crystalline powder with an extremely bitter taste. It is a natural isoquinoline alkaloid antibiotic with multiple biological activities and pharmacological effects. It is mainly used to treat gastroenteritis, bacterial dysentery and other intestinal infections, conjunctivitis, suppurative otitis media, etc. It inhibits various Gram-positive and Gram-negative bacteria such as hemolytic Streptococcus, Vibrio cholerae, Staphylococcus aureus, and meningococci to achieve the effect of inhibition at low concentrations and bactericidal at high concentrations.
[0003] In related technologies, berberine is mainly produced through natural plant extraction and chemical synthesis. The chemical synthesis method requires washing the finished product during production, generating a large amount of wastewater (such as berberine copper-containing wastewater and berberine mother liquor wastewater), which is berberine pharmaceutical wastewater.
[0004] Berberine pharmaceutical wastewater is a typical antibiotic wastewater, which contains high concentrations of berberine, copper ions and dichromate index (COD Cr ) is high. Since berberine pharmaceutical wastewater contains a high concentration of berberine, it has a strong antibacterial effect and strong microbial toxicity to the wastewater, which leads to great difficulties in aerobic treatment and anaerobic treatment. It has poor biodegradability and it is difficult to effectively treat berberine pharmaceutical wastewater by conventional biochemical treatment. Utility Model Content
[0005] In view of the shortcomings of the existing technology mentioned above, the utility model provides a berberine pharmaceutical wastewater treatment system to solve the technical problems such as the high concentration of berberine contained in the above-mentioned berberine pharmaceutical wastewater, which has a strong antibacterial effect and strong microbial toxicity on the wastewater, resulting in great difficulties in aerobic treatment and anaerobic treatment, poor biodegradability, and difficulty in effectively treating berberine pharmaceutical wastewater using conventional biochemical treatment.
[0006] To achieve the above objectives, the solution of this application is as follows:
[0007] In the first aspect, the utility model provides a berberine pharmaceutical wastewater treatment system, which includes a reactor, a first dehydration device, a macroporous adsorption resin column, a resin filter and a biochemical treatment device connected in sequence. The reactor is used as a place for alkaline substances to react with copper ions in the wastewater to generate copper hydroxide, and copper hydroxide to react with hydrated copper chloride in the wastewater to generate basic copper chloride precipitate.
[0008] The principle of the berberine pharmaceutical wastewater treatment system of the present invention is as follows: by arranging a reactor, a first dehydration device, a macroporous adsorption resin column, a resin filter and a biochemical treatment device which are connected in sequence, alkaline substances such as sodium hydroxide can be added into the reactor to make the alkaline substances such as sodium hydroxide react with copper ions in the wastewater to generate copper hydroxide, and the copper hydroxide further reacts with substances such as hydrated copper chloride contained in the wastewater to generate basic copper chloride precipitate, thereby effectively removing impurities such as copper ions and chloride ions in the wastewater, and adsorbing berberine in the wastewater by the resin in the resin filter, thereby effectively removing berberine from the wastewater, making it convenient for the downstream biochemical treatment device to treat impurities such as other organic matter in the wastewater except berberine, and solving the technical problem that the berberine pharmaceutical wastewater contains a high concentration of berberine, has a strong antibacterial effect and strong microbial toxicity to the wastewater, leads to great difficulties in aerobic treatment and anaerobic treatment, has poor biodegradability, and is difficult to effectively treat the berberine pharmaceutical wastewater by conventional biochemical treatment.
[0009] Optionally, the resin filter is a macroporous resin filter.
[0010] Optionally, the resin filter is an N-hydroxymethyl acrylamide resin (ie, HAM resin) filter.
[0011] Specifically, this embodiment configures the resin filter 3 to be an N-hydroxymethyl acrylamide resin (ie, HAM resin) filter, thereby utilizing the excellent adsorption performance of HAM resin on berberine to improve the removal effect of berberine, thereby further improving water quality.
[0012] Optionally, a delivery pump is provided on the connecting pipe between the reactor and the first dehydration device.
[0013] Optionally, the berberine pharmaceutical wastewater treatment system further includes an ion exchange resin column, which is located on a connecting pipe between the first dehydration device and the macroporous resin exchange column, and the first end of the ion exchange resin column is connected to the liquid phase outlet of the first dehydration device.
[0014] Specifically, the utility model can further purify the water quality by adding an ion exchange resin column located on the connecting pipe between the reactor and the first dehydration device, so as to adsorb unreacted copper ions in the wastewater through the ion exchange resin column.
[0015] Optionally, the first dehydration device is a filter press.
[0016] Optionally, the resin filter is provided with a berberine outlet, and the berberine pharmaceutical wastewater treatment system further comprises a resin desorption column, which is connected to the berberine outlet of the resin filter.
[0017] Specifically, the utility model adds a resin desorption column connected to the berberine outlet of the resin filter, so that the berberine adsorbed by the resin filter can be removed by the resin desorption column, and the berberine can be recovered, thereby improving resource utilization and increasing profits.
[0018] Optionally, the resin desorption column is a macroporous resin desorption column.
[0019] Optionally, the resin desorption column is provided with a berberine discharge port, and the berberine pharmaceutical wastewater treatment system further comprises a berberine storage container, which is connected to the berberine discharge port of the resin desorption column.
[0020] Optionally, the first dehydration device is provided with a solid phase outlet, and the berberine pharmaceutical wastewater treatment system further includes a second dehydration device and a drying device connected in sequence, the second dehydration device is provided with a feed port, the feed port is connected to the solid phase outlet of the first dehydration device, the second dehydration device is located below the first dehydration device, and the drying device is located below the second dehydration device.
[0021] Specifically, the utility model adds a second dehydration device and a drying device which are connected in sequence, and connects the feed port of the second dehydration device to the solid phase outlet of the first dehydration device. The second dehydration device is located below the first dehydration device, and can recover the basic copper chloride precipitate obtained after the reaction in the reactor, thereby improving resource utilization and increasing profits.
[0022] Optionally, the berberine pharmaceutical wastewater treatment system further includes a cleaning device, which is located on the connecting pipe between the second dehydration device and the drying device.
[0023] Specifically, the utility model can clean the impurity ions on the surface of the basic copper chloride precipitate and improve the purity of the obtained basic copper chloride by-product by adding a cleaning device located on the connecting pipe between the second dehydration device and the drying device.
[0024] Optionally, the second dehydration device is a solid-liquid separator or a dehydrator. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the structures shown in these drawings without paying any creative work.
[0026] Figure 1This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 1;
[0027] Figure 2 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 2;
[0028] Figure 3 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 3;
[0029] Figure 4 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 4;
[0030] Figure 5 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 5;
[0031] Figure 6 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of Example 6.
[0032] Reference numerals
[0033] 1 reactor;
[0034] 2-first dehydration device;
[0035] 3-macroporous adsorption resin column;
[0036] 4-resin filter;
[0037] 5-Biochemical treatment device;
[0038] 6-ion exchange resin column;
[0039] 7-resin desorption column;
[0040] 8-Berberine storage container;
[0041] 9- second dehydration device;
[0042] 10- drying device;
[0043] 11- cleaning device;
[0044] 12- Delivery pump. DETAILED DESCRIPTION
[0045] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the embodiments described are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.
[0046] It should be noted that all directional indications (such as up, down, left, right, front, back, etc.) in the embodiments of the present invention are only used to explain the relative position relationship, movement status, etc. between the various components under a certain specific posture (as shown in the accompanying drawings). If the specific posture changes, the directional indication will also change accordingly.
[0047] In this utility model, unless otherwise specified or limited, the terms "connection" and "fixation" should be understood in a broad sense. For example, "fixation" can mean fixed connection, detachable connection, or integration; mechanical connection or electrical connection; direct connection or indirect connection through an intermediate medium; internal communication between two elements or interaction between two elements, unless otherwise specified. For those skilled in the art, the specific meanings of the above terms in this utility model can be understood according to specific circumstances.
[0048] In addition, in this utility model, the descriptions of "first" and "second" are for descriptive purposes only and should not be understood as indicating or implying their relative importance or implicitly indicating the number of the technical features indicated. Therefore, the features specified as "first" and "second" may explicitly or implicitly include at least one of such features. In addition, the technical solutions between the various embodiments can be combined with each other, but this must be based on the fact that they can be implemented by ordinary technicians in this field. When the combination of technical solutions is mutually contradictory or cannot be implemented, it should be deemed that such combination of technical solutions does not exist and is not within the scope of protection required by this utility model.
[0049] In related technologies, berberine pharmaceutical wastewater contains a relatively high concentration of berberine, which has a strong antibacterial effect and strong microbial toxicity on wastewater, resulting in great difficulties in aerobic treatment and anaerobic treatment. It has poor biodegradability and it is difficult to effectively treat berberine pharmaceutical wastewater using conventional biochemical treatment.
[0050] Based on the above technical problems, one embodiment of the utility model provides a berberine pharmaceutical wastewater treatment system, which includes a reactor 1, a first dehydration device 2, a macroporous adsorption resin column 3, a resin filter 4 and a biochemical treatment device 5 connected in sequence. The reactor 1 is used as a place for alkaline substances to react with copper ions in the wastewater to generate copper hydroxide, and copper hydroxide reacts with hydrated copper chloride in the wastewater to generate basic copper chloride precipitate. The first dehydration device 2 adopts a filter press, and the first dehydration device 2 is provided with a solid phase outlet and a liquid phase outlet, a macroporous resin adsorption column 3, and the resin filter 4 adopts an N-hydroxymethyl acrylamide resin filter. The resin filter 4 is provided with a berberine outlet.
[0051] In another embodiment of the present application, the berberine pharmaceutical wastewater treatment system further comprises an ion exchange resin column 6, the ion exchange resin column 6 is located on the communication pipeline between the first dewatering device 2 and the macroporous resin exchange column 3, and a first end of the ion exchange resin column 6 is communicated with a liquid phase outlet of the first dewatering device 2.
[0052] In another embodiment of the present application, the berberine pharmaceutical wastewater treatment system further comprises a resin desorption column 7, the resin desorption column 7 is communicated with a berberine outlet of the macroporous resin adsorption column 3, and the resin desorption column 7 is provided with a berberine discharge outlet.
[0053] In another embodiment of the present application, the berberine pharmaceutical wastewater treatment system further comprises a berberine storage container 8, the berberine storage container 8 is communicated with the berberine discharge outlet of the resin desorption column 7.
[0054] In another embodiment of the present application, the berberine pharmaceutical wastewater treatment system further comprises a second dewatering device 9 and a drying device 10 which are communicated in sequence, the second dewatering device is provided with a feeding port 9, the feeding port is communicated with a solid phase outlet of the first dewatering device 2, the second dewatering device 9 is located below the first dewatering device 2, the drying device 10 is located below the second dewatering device 9, and the second dewatering device 9 adopts a solid-liquid separator or a dewatering machine.
[0055] In another embodiment of the present application, the berberine pharmaceutical wastewater treatment system further comprises a cleaning device 11, the cleaning device 11 is located on the communication pipeline between the second dewatering device 9 and the drying device 10.
[0056] Another embodiment of the present application further provides a berberine pharmaceutical system, which comprises the berberine pharmaceutical wastewater treatment system as described above.
[0057] In the following description, a large number of details are discussed to provide a more thorough explanation of the embodiments of the present application, however, it is obvious for those skilled in the art that the embodiments of the present application can be implemented without these specific details.
[0058] Embodiment 1
[0059] Please refer to Figure 1 , Figure 1 Fig. 1 is a structural schematic diagram of a berberine pharmaceutical wastewater treatment system according to the present application, the berberine pharmaceutical wastewater treatment system is used for treating wastewater generated in a berberine production process, and the berberine pharmaceutical wastewater treatment system comprises a reactor 1, a first dewatering device 2, a macroporous adsorption resin column 3, a resin filter 4 and a biochemical treatment device 5 which are communicated in sequence.
[0060] Please continue to refer to Figure 1Reactor 1 is used as a place for alkaline substances such as sodium hydroxide to react with copper ions in wastewater. In reactor 1, alkaline substances such as sodium hydroxide react with copper ions in wastewater to generate copper hydroxide. Copper hydroxide further reacts with substances such as hydrated copper chloride contained in the wastewater to generate basic copper chloride precipitate (because basic copper chloride is a crystalline powder, it is called crystalline precipitate here), thereby effectively removing impurities such as copper ions and chloride ions in the wastewater. By adding a macroporous adsorption resin column, berberine in the wastewater is adsorbed, thereby effectively removing berberine in the wastewater. Reactor 1 is provided with a liquid inlet, a feed inlet and a discharge inlet. The liquid inlet is used as a channel for copper-containing wastewater to enter reactor 1, the feed inlet is used as a channel for alkaline substances such as sodium hydroxide to enter reactor 1, and the discharge inlet is used as a channel for the reaction mixture to be discharged from reactor 1 to the outside.
[0061] Please continue reading Figure 1 The first dehydration device 2 is used to perform solid-liquid separation on the reaction mixture in the reactor 1. The first dehydration device 2 is provided with a feed inlet, a solid phase outlet, and a liquid phase outlet. The feed inlet of the first dehydration device 2 is connected to the discharge port of the reactor 1. A delivery pump 12 is provided on the connecting pipe between the feed inlet of the first dehydration device 2 and the discharge port of the reactor 1. The delivery pump 12 can be a screw pump, and the first dehydration device 2 can be a filter press. The screw pump and the filter press are prior art and will not be described in detail here.
[0062] Please continue reading Figure 1 The macroporous resin adsorption column 3 is used to adsorb impurities such as unreacted copper ions in the wastewater. The macroporous resin adsorption column 3 has a liquid inlet and a liquid outlet. The liquid inlet of the macroporous resin adsorption column 3 is connected to the liquid outlet of the first dehydration device 2. The macroporous resin adsorption column 4 can be a D401 macroporous resin adsorption column. The D401 macroporous resin adsorption column is a prior art and will not be described in detail here.
[0063] Please continue reading Figure 1 Resin filter 4 is used to remove large particles, suspended matter, berberine, and other impurities from the wastewater through adsorption and exchange with a macroporous resin. Resin filter 4 is equipped with a liquid inlet, a liquid outlet, a liquid inlet end, and a berberine outlet. The liquid inlet of resin filter 4 is connected to the liquid outlet of the macroporous resin adsorption column 3, and the liquid inlet end of resin filter 4 is connected to the berberine mother liquor wastewater inlet pipeline (i.e., the macroporous resin filter can process wastewater treated by the macroporous resin adsorption column 3 as well as fresh berberine mother liquor wastewater). Resin filter 4 utilizes an N-hydroxymethyl acrylamide resin (i.e., HAM resin) filter. HAM resin filters are known in the art and will not be described in detail here.
[0064] Specifically, this embodiment configures the resin filter 4 to be an N-hydroxymethyl acrylamide resin (ie, HAM resin) filter, thereby utilizing the excellent adsorption performance of HAM resin on berberine to improve the removal effect of berberine, thereby further improving water quality.
[0065] Please continue reading Figure 1 The biochemical treatment device 5 is used to remove organic matter, nitrogen, and phosphorus from the wastewater through denitrification, nitrification, and phosphorus uptake by phosphate-accumulating bacteria under aerobic conditions, further purifying the water. The biochemical treatment device 5 has a liquid inlet and a purified water outlet. The liquid inlet of the biochemical treatment device 5 is connected to the liquid outlet of the resin filter 4. The biochemical treatment device 5 can utilize an anoxic-aerobic tank, which is conventional technology and will not be described in detail here.
[0066] The principle of the berberine pharmaceutical wastewater treatment system of this embodiment is: by setting a reactor 1, a first dehydration device 2, a macroporous adsorption resin column 3, a resin filter 4 and a biochemical treatment device 5 that are connected in sequence, alkaline substances such as sodium hydroxide can be added to the reactor 1 to make the alkaline substances such as sodium hydroxide react with copper ions in the wastewater to generate copper hydroxide, and the copper hydroxide further reacts with substances such as hydrated copper chloride contained in the wastewater to generate basic copper chloride precipitate, thereby effectively removing impurities such as copper ions and chloride ions in the wastewater, and adsorbing berberine in the wastewater by the resin in the resin filter 4, thereby effectively removing berberine from the wastewater, making it easier for the downstream biochemical treatment device to treat other organic matter and other impurities in the wastewater in addition to berberine, thereby solving the technical problem that the berberine pharmaceutical wastewater contains a high concentration of berberine, which has a strong antibacterial effect and strong microbial toxicity on the wastewater, resulting in great difficulties in aerobic treatment and anaerobic treatment, poor biodegradability, and is difficult to effectively treat the berberine pharmaceutical wastewater using conventional biochemical treatment.
[0067] Example 2
[0068] See also Figure 2 , Figure 2 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of this embodiment.
[0069] Please continue reading Figure 2 The difference between this embodiment and embodiment 1 is that it also includes an ion exchange resin column 6, which is located on the connecting pipe between the first dehydration device 2 and the macroporous resin exchange column 3, and the first end of the ion exchange resin column 6 is connected to the liquid phase outlet of the first dehydration device 2.
[0070] Specifically, this embodiment adds an ion exchange resin column 6 located on the connecting pipe between the first dehydration device 2 and the macroporous resin exchange column 3, so that the unreacted copper ions in the wastewater can be adsorbed by the ion exchange resin column 6 to further purify the water quality.
[0071] Example 3
[0072] See also Figure 3 , Figure 3 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of this embodiment.
[0073] Please continue reading Figure 3 The difference between this embodiment and Example 2 is that: it also includes a resin desorption column 7, the resin desorption column 7 is connected to the berberine outlet of the resin filter 4, the resin desorption column 7 is provided with a berberine discharge port, and the resin desorption column 7 adopts a macroporous resin desorption column.
[0074] Specifically, this embodiment adds a resin desorption column 7 connected to the berberine outlet of the resin filter 4. The resin desorption column 7 can be used to remove the berberine adsorbed by the resin filter 4, and then recover the berberine, thereby improving resource utilization and increasing profits.
[0075] Example 4
[0076] See also Figure 4 , Figure 4 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of this embodiment.
[0077] Please continue reading Figure 4 The difference between this embodiment and embodiment 3 is that: it further includes a berberine storage container 8, and the berberine storage container 8 is connected to the berberine discharge port of the resin desorption column 7.
[0078] Example 5
[0079] See also Figure 5 , Figure 5 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of this embodiment.
[0080] Please continue reading Figure 5 This embodiment differs from Embodiment 4 in that it further includes a second dehydration device 9 and a drying device 10, which are connected in sequence. The second dehydration device 10 has a feed port connected to the solid phase outlet of the first dehydration device 2. The second dehydration device 10 is located below the first dehydration device 2, and the drying device 10 is located below the second dehydration device 9. The second dehydration device 9 can be a solid-liquid separator, a dehydrator, or the like. Solid-liquid separators and dehydrators are conventional technologies and will not be described in detail here.
[0081] Specifically, this embodiment adds a second dehydration device 9 and a drying device 10 which are connected in sequence, the feed port of the second dehydration device 10 is connected to the solid phase outlet of the first dehydration device 2, and the second dehydration device 10 is arranged to be located below the first dehydration device 2, so as to recover the basic copper chloride precipitate obtained after the reaction in the reactor 1, thereby improving resource utilization and increasing profits.
[0082] Example 6
[0083] See also Figure 6 , Figure 6 This is a schematic structural diagram of the berberine pharmaceutical wastewater treatment system of this embodiment.
[0084] Please continue reading Figure 6 The difference between this embodiment and embodiment 5 is that it further includes a cleaning device 11, which is located on the connecting pipe between the second dehydration device 9 and the drying device 10.
[0085] Specifically, this embodiment can clean the impurity ions on the surface of the basic copper chloride precipitate by adding a cleaning device 11 located on the connecting pipe between the second dehydration device 9 and the drying device 10, thereby improving the purity of the obtained basic copper chloride by-product.
[0086] The above embodiments are merely illustrative of the principles and effects of the present invention and are not intended to limit the present invention. Anyone skilled in the art may modify or alter the above embodiments without departing from the spirit and scope of the present invention. Therefore, any equivalent modifications or alterations made by one of ordinary skill in the art without departing from the spirit and technical concepts disclosed herein shall be covered by the claims of the present invention.
Claims
1. A berberine pharmaceutical wastewater treatment system, characterized in that: The berberine pharmaceutical wastewater treatment system includes a reactor, a first dehydration device, a macroporous adsorption resin column, a resin filter and a biochemical treatment device that are connected in sequence. The reactor is used as a place for alkaline substances to react with copper ions in the wastewater to generate copper hydroxide, and copper hydroxide to react with hydrated copper chloride in the wastewater to generate basic copper chloride precipitate.
2. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: The resin filter is an N-hydroxymethyl acrylamide resin filter.
3. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: A delivery pump is provided on the communicating pipeline between the reactor and the first dehydration device.
4. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: The first dehydration device is provided with a liquid phase outlet, and the berberine pharmaceutical wastewater treatment system also includes an ion exchange resin column, which is located on the connecting pipe between the first dehydration device and the macroporous adsorption resin column, and the first end of the ion exchange resin column is connected to the liquid phase outlet of the first dehydration device.
5. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: The first dehydration device is a filter press.
6. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: The resin filter is provided with a berberine outlet, and the berberine pharmaceutical wastewater treatment system further comprises a resin desorption column, which is connected to the berberine outlet of the resin filter.
7. The berberine pharmaceutical wastewater treatment system according to claim 6, characterized in that: The resin desorption column is provided with a berberine discharge port, and the berberine pharmaceutical wastewater treatment system further comprises a berberine storage container, which is connected to the berberine discharge port of the resin desorption column.
8. The berberine pharmaceutical wastewater treatment system according to claim 1, characterized in that: The first dehydration device is provided with a solid phase outlet, and the berberine pharmaceutical wastewater treatment system also includes a second dehydration device and a drying device connected in sequence. The second dehydration device is provided with a feed port, and the feed port is connected to the solid phase outlet of the first dehydration device. The second dehydration device is located below the first dehydration device, and the drying device is located below the second dehydration device.
9. The berberine pharmaceutical wastewater treatment system according to claim 8, characterized in that: The berberine pharmaceutical wastewater treatment system also includes a cleaning device, which is located on the connecting pipe between the second dehydration device and the drying device.
10. The berberine pharmaceutical wastewater treatment system according to claim 8, characterized in that: The second dehydration device is a solid-liquid separator or a dehydrator.